EP1148877A4 - Methods for inhibiting bone resorption - Google Patents
Methods for inhibiting bone resorptionInfo
- Publication number
- EP1148877A4 EP1148877A4 EP99970321A EP99970321A EP1148877A4 EP 1148877 A4 EP1148877 A4 EP 1148877A4 EP 99970321 A EP99970321 A EP 99970321A EP 99970321 A EP99970321 A EP 99970321A EP 1148877 A4 EP1148877 A4 EP 1148877A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- bone resorption
- inhibiting bone
- inhibiting
- resorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10433998P | 1998-10-15 | 1998-10-15 | |
US104339P | 1998-10-15 | ||
GB9824572 | 1998-11-09 | ||
GBGB9824572.3A GB9824572D0 (en) | 1998-11-09 | 1998-11-09 | Methods for inhibiting bone resorption |
PCT/US1999/023616 WO2000021532A1 (en) | 1998-10-15 | 1999-10-12 | Methods for inhibiting bone resorption |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1148877A1 EP1148877A1 (en) | 2001-10-31 |
EP1148877A4 true EP1148877A4 (en) | 2003-01-22 |
Family
ID=26314644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99970321A Withdrawn EP1148877A4 (en) | 1998-10-15 | 1999-10-12 | Methods for inhibiting bone resorption |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1148877A4 (en) |
JP (1) | JP2002527393A (en) |
AU (1) | AU1444200A (en) |
CA (1) | CA2346038A1 (en) |
WO (1) | WO2000021532A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720270D0 (en) | 1997-09-25 | 1997-11-26 | Pharmagene Lab Limited | Medicaments for the treatment of migraine |
CN1413190A (en) * | 1999-12-22 | 2003-04-23 | 辉瑞产品公司 | EP4 receptor selective agonists in treatment of osteoporosis |
HN2001000224A (en) | 2000-10-19 | 2002-06-13 | Pfizer | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS. |
SK5562003A3 (en) | 2000-11-27 | 2004-08-03 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
GB0031315D0 (en) * | 2000-12-21 | 2001-02-07 | Glaxo Group Ltd | Indole derivatives |
GB0103269D0 (en) | 2001-02-09 | 2001-03-28 | Glaxo Group Ltd | Napthalene derivatives |
AU2002328338C1 (en) | 2001-07-16 | 2009-01-08 | Ono Pharmaceutical Co., Ltd | 2 pyrrolidone derivatives as prostanoid agonists |
PL368046A1 (en) | 2001-07-16 | 2005-03-21 | F.Hoffmann-La Roche Ag | Prostaglandin analogues_as ep4 receptor agonists |
KR20070087078A (en) | 2001-07-23 | 2007-08-27 | 오노 야꾸힝 고교 가부시키가이샤 | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
WO2003030911A1 (en) * | 2001-10-08 | 2003-04-17 | Medical Research Council | Use of prostaglandin e synthase inhibitors, or ep2 or ep4 receptor antagonists, in the treatment of a pathological condition of the uterus |
JP2006515015A (en) | 2003-01-10 | 2006-05-18 | エフ.ホフマン−ラ ロシュ アーゲー | 2-Piperidone derivatives as prostaglandin agonists |
US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
UY30121A1 (en) | 2006-02-03 | 2007-08-31 | Glaxo Group Ltd | NEW COMPOUNDS |
US20080167377A1 (en) | 2006-12-15 | 2008-07-10 | Alessandra Gaiba | Novel compounds |
GB0721611D0 (en) | 2007-11-02 | 2007-12-12 | Glaxo Group Ltd | Novel compounds |
JPWO2010087425A1 (en) | 2009-01-30 | 2012-08-02 | 国立大学法人京都大学 | Prostate cancer progression inhibitor and progression inhibition method |
JP2015522528A (en) | 2012-05-09 | 2015-08-06 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Method and pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0526001A1 (en) * | 1991-07-03 | 1993-02-03 | Merck & Co. Inc. | Substituted triazolinones |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411980A (en) * | 1989-07-28 | 1995-05-02 | Merck & Co., Inc. | Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
-
1999
- 1999-10-12 EP EP99970321A patent/EP1148877A4/en not_active Withdrawn
- 1999-10-12 WO PCT/US1999/023616 patent/WO2000021532A1/en not_active Application Discontinuation
- 1999-10-12 CA CA002346038A patent/CA2346038A1/en not_active Abandoned
- 1999-10-12 JP JP2000575508A patent/JP2002527393A/en not_active Withdrawn
- 1999-10-12 AU AU14442/00A patent/AU1444200A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0526001A1 (en) * | 1991-07-03 | 1993-02-03 | Merck & Co. Inc. | Substituted triazolinones |
Non-Patent Citations (1)
Title |
---|
See also references of WO0021532A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2346038A1 (en) | 2000-04-20 |
AU1444200A (en) | 2000-05-01 |
EP1148877A1 (en) | 2001-10-31 |
WO2000021532A1 (en) | 2000-04-20 |
JP2002527393A (en) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1088333A4 (en) | Compositions and methods for inhibiting bone resorption | |
HUP0104836A3 (en) | Bone fixation system | |
HK1021499A1 (en) | A surgical system for dermablation | |
HU9904702D0 (en) | Method for providing refrigeration | |
IL118196A0 (en) | Methods for inhibiting bone loss | |
AU3359697A (en) | Bone resorption inhibitors | |
GB9812103D0 (en) | Surgical implant | |
EP1148877A4 (en) | Methods for inhibiting bone resorption | |
GB9819243D0 (en) | Method for inhibiting bone resorption | |
EP1089750A4 (en) | Compositions and methods for inhibiting bone resorption | |
GB9824572D0 (en) | Methods for inhibiting bone resorption | |
EP1142579A4 (en) | Bone resorption inhibitors | |
AU137972S (en) | Implant | |
GB9810885D0 (en) | Methods of inhibiting bone resorption | |
GB9809791D0 (en) | Methods of inhibiting bone resorption | |
GB9822699D0 (en) | Methods of inhibiting bone resorption | |
GB9819126D0 (en) | Compositions and methods for inhibiting bone resorption | |
GB9817170D0 (en) | Compositions and methods for inhibiting bone resorption | |
GB9822330D0 (en) | Compositions and methods for inhibiting bone resorption | |
AU741818C (en) | Method for inhibiting bone resorption | |
GB9826207D0 (en) | Bone conditions | |
GB9821388D0 (en) | Spinal implants | |
GB9824574D0 (en) | Methods for regulating bone formation | |
HU9801479D0 (en) | Mechanical tachitoscope for improving fixation width | |
ZA986040B (en) | Orthopedic supports |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010515 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010515;LT PAYMENT 20010515;LV PAYMENT 20010515;MK PAYMENT 20010515;RO PAYMENT 20010515;SI PAYMENT 20010515 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20021205 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030522 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040309 |